PRE Q3 2024 Earnings — Prenetics Global Limited Revenue & Financial Results | Market Cap Arena

PREPrenetics Global Limited

$287M

Q3 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$8M+59.4% YoY

Gross Profit

$4M50.8% margin

Operating Income

-$12M-151.8% margin

Net Income

-$11M-137.2% margin

EPS (Diluted)

$-0.84

QoQ Revenue Growth

+30.9%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$236M

Total Liabilities

$56M

Stockholders' Equity

$179M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$5M	+59.4%
Gross Profit	$4M	$2M	+138.6%
Operating Income	-$12M	-$13M	+8.8%
Net Income	-$11M	-$14M	+21.4%